108 related articles for article (PubMed ID: 23722623)
1. Cancer detection rates following enrolment in a disease management programme for type 2 diabetes.
Geier AS; Wellmann J; Wellmann I; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetologia; 2013 Sep; 56(9):1944-8. PubMed ID: 23722623
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.
Bozorgmehr K; San Sebastian M; Brenner H; Razum O; Maier W; Saum KU; Holleczek B; Miksch A; Szecsenyi J
Int J Equity Health; 2015 Mar; 14():28. PubMed ID: 25879523
[TBL] [Abstract][Full Text] [Related]
4. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.
Johnson JA; Bowker SL; Richardson K; Marra CA
Diabetologia; 2011 Sep; 54(9):2263-71. PubMed ID: 21748485
[TBL] [Abstract][Full Text] [Related]
5. [Linkage of secondary data with cancer registry data on the basis of encrypted personal identifiers - results from a pilot study in North Rhine-Westphalia].
Kajüter H; Batzler WU; Krieg V; Heidinger O; Hense HW
Gesundheitswesen; 2012 Aug; 74(8-9):e84-9. PubMed ID: 22836935
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data.
Fang Y; Zhang X; Xu H; Smith-Warner SA; Xu D; Fang H; Xu WH
Endocr Connect; 2018 Dec; 7(12):1415-1423. PubMed ID: 30475218
[TBL] [Abstract][Full Text] [Related]
7. Autonomic function is not associated with the incidence of type 2 diabetes in a high-risk population: the Hoorn study.
Hillebrand S; de Mutsert R; den Heijer M; le Cessie S; Stehouwer CD; Nijpels G; Dekker JM
Diabetes Metab; 2014 Apr; 40(2):128-36. PubMed ID: 24308949
[TBL] [Abstract][Full Text] [Related]
8. Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis.
Bozorgmehr K; Maier W; Brenner H; Saum KU; Stock C; Miksch A; Holleczek B; Szecsenyi J; Razum O
J Epidemiol Community Health; 2015 Nov; 69(11):1091-101. PubMed ID: 26082518
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences.
Schäfer I; Küver C; Gedrose B; Hoffmann F; Russ-Thiel B; Brose HP; van den Bussche H; Kaduszkiewicz H
BMC Health Serv Res; 2010 Mar; 10():55. PubMed ID: 20199685
[TBL] [Abstract][Full Text] [Related]
11. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
12. Risk of cancer following hospitalization for type 2 diabetes.
Hemminki K; Li X; Sundquist J; Sundquist K
Oncologist; 2010; 15(6):548-55. PubMed ID: 20479278
[TBL] [Abstract][Full Text] [Related]
13. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).
Schrijnders D; Hendriks SH; Kleefstra N; Vissers PAJ; Johnson JA; de Bock GH; Bilo HJG; Landman GWD
PLoS One; 2018; 13(1):e0190870. PubMed ID: 29370205
[TBL] [Abstract][Full Text] [Related]
15. Excess risk of primary liver cancer in patients with diabetes mellitus.
Adami HO; Chow WH; Nyrén O; Berne C; Linet MS; Ekbom A; Wolk A; McLaughlin JK; Fraumeni JF
J Natl Cancer Inst; 1996 Oct; 88(20):1472-7. PubMed ID: 8841022
[TBL] [Abstract][Full Text] [Related]
16. Diabetes Mellitus as Cancer Risk: A 14-year, Cross-Sectional Analysis.
Saewai C; Fumaneeshoat O; Thongsuksai P; Ingviya T
Nutr Cancer; 2023; 75(6):1454-1463. PubMed ID: 37099762
[TBL] [Abstract][Full Text] [Related]
17. Cancer occurrence in Danish diabetic patients: duration and insulin effects.
Carstensen B; Witte DR; Friis S
Diabetologia; 2012 Apr; 55(4):948-58. PubMed ID: 22120574
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation.
Harding JL; Shaw JE; Peeters A; Cartensen B; Magliano DJ
Diabetes Care; 2015 Feb; 38(2):264-70. PubMed ID: 25488912
[TBL] [Abstract][Full Text] [Related]
19. Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study.
De Bruijn KM; Ruiter R; de Keyser CE; Hofman A; Stricker BH; van Eijck CH
Eur J Cancer; 2014 Sep; 50(14):2449-55. PubMed ID: 25047425
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.
Wideroff L; Gridley G; Mellemkjaer L; Chow WH; Linet M; Keehn S; Borch-Johnsen K; Olsen JH
J Natl Cancer Inst; 1997 Sep; 89(18):1360-5. PubMed ID: 9308706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
